Trial Search Results

Meru Health Ascend Mobile Intervention for Depression in Middle Aged and Older Adults

Using technology to deliver depression interventions is one way could alleviate the public health burden of depression. The study is testing a mobile app intervention program for depression that uses cognitive behavioral skills and mindfulness. This study seeks to obtain feedback on the intervention and refine the intervention and then test the intervention in a larger study. The mobile app intervention called the Meru Health Ascend program consists of the app and therapist support via messaging within the app.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Palo Alto Veterans Institute for Research

Collaborator: Stanford University

Stanford Investigator(s):


  • Behavioral: Meru Health Ascend Program


Phase 2/Phase 3


Inclusion Criteria:

   - Owns a smart phone, resides in California, PHQ-9 score greater than or equal to 10,
   stable dose of medication (if taking psychotropic), able to read and understand

Exclusion Criteria:

   - Psychotic disorder, possible cognitive impairment, evidence of problematic drinking
   behavior, active suicide ideation with a plan, active psychological treatment, bipolar
   disorder (study 2 only)

Ages Eligible for Study

40 Years - 120 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Christine Gould, PhD
650-493-5000 Ext. 68899